Cigna's strong growth potential, Evernorth expansion, and stock buybacks make it undervalued. Click here to find out why CI ...

David Cordani; Chairman of the Board, President, Chief Executive Officer; Cigna Group Brian Evanko; Chief Financial Officer, Executive Vice President, President and Chief Executive Office - Cigna ...

Progyny Inc (PGNY) reports strong financial performance with record ART cycles and strategic expansions, despite challenges ...

Learn more here. Operator Thank you for standing by for the Cigna Group's fourth quarter 2024 results review. At this time, all callers are in a listen-only mode. We will conduct a question-and ...

Cigna's actual EPS of $6.64 for Q4 fell short of the forecasted $7.79, representing a 14.7% miss. However, revenue of $65.65 billion surpassed expectations by 3.9%, indicating strong top-line ...

Cigna Corp (NYSE:CI) reported its fourth-quarter 2024 earnings, revealing a notable miss on earnings per share (EPS) despite surpassing revenue expectations. The company's stock reacted negatively in ...

US managed care insurers' Q4 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to ...

David Cordani; Chairman of the Board, President, Chief Executive Officer; Cigna Group Brian Evanko; Chief Financial Officer, Executive Vice President, President and Chief Executive Office - Cigna ...

The firm notes Cigna’s Q4 miss was primarily caused by stop-loss pressures related to high-cost individual claims in 2024, which are expected to continue into 2025. Oppenheimer believes Cigna ...

Aristotle Atlantic Core Equity Strategy highlighted stocks like The Cigna Group (NYSE:CI) in its Q4 2024 investor letter and explained its insights for the company. The Cigna Group (NYSE:CI) is a ...